Current Ratio of Syros Pharmaceuticals, Inc. from 31 Mar 2017 to 30 Sep 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Syros Pharmaceuticals, Inc. quarterly Current Ratio in % history and change rate from 31 Mar 2017 to 30 Sep 2024.
  • Syros Pharmaceuticals, Inc. Current Ratio for the quarter ending 30 Sep 2024 was 320%, a 46% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Syros Pharmaceuticals, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2024 320% -274% -46% 30 Sep 2024
Q2 2024 366% -286% -44% 30 Jun 2024
Q1 2024 407% -147% -26% 31 Mar 2024
Q4 2023 507% +12% +2.5% 31 Dec 2023
Q3 2023 594% +156% +36% 30 Sep 2023
Q2 2023 652% +263% +67% 30 Jun 2023
Q1 2023 554% +46% +9% 31 Mar 2023
Q4 2022 495% -109% -18% 31 Dec 2022
Q3 2022 438% -218% -33% 30 Sep 2022
Q2 2022 390% -228% -37% 30 Jun 2022
Q1 2022 508% -66% -12% 31 Mar 2022
Q4 2021 604% +87% +17% 31 Dec 2021
Q3 2021 656% +179% +38% 30 Sep 2021
Q2 2021 618% +97% +19% 30 Jun 2021
Q1 2021 575% -11% -1.9% 31 Mar 2021
Q4 2020 517% -43% -7.7% 31 Dec 2020
Q3 2020 477% -96% -17% 30 Sep 2020
Q2 2020 520% -69% -12% 30 Jun 2020
Q1 2020 586% +11% +2% 31 Mar 2020
Q4 2019 560% -26% -4.4% 31 Dec 2019
Q3 2019 573% -31% -5.1% 30 Sep 2019
Q2 2019 590% -81% -12% 30 Jun 2019
Q1 2019 574% -171% -23% 31 Mar 2019
Q4 2018 586% -321% -35% 31 Dec 2018
Q3 2018 604% -419% -41% 30 Sep 2018
Q2 2018 670% -418% -38% 30 Jun 2018
Q1 2018 746% -241% -24% 31 Mar 2018
Q4 2017 906% 31 Dec 2017
Q3 2017 1023% 30 Sep 2017
Q2 2017 1088% 30 Jun 2017
Q1 2017 986% 31 Mar 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.